Inactivation of p14ARF as a key event for the progression of adult T cell leukemia/lymphoma

Leukemia Research

Volumn 31, Issue 12, 2007, Pages 1625-1632

  Kohno, Tomoko ^a   Yamada, Yasuaki ^a   Tawara, Masayuki ^a   Takasaki, Yumi ^a   Kamihira, Shimeru ^a   Tomonaga, Masao ^a   Matsuyama, Toshifumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

ATLL; P53; Pokemon; Prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA;

ACUTE DISEASE; ADULT; ARTICLE; CHRONIC DISEASE; DISEASE COURSE; GENETICS; HUMAN; METABOLISM; MORTALITY; MUTATION; PATHOLOGY; POLYMERASE CHAIN REACTION; PROGNOSIS; SURVIVAL RATE; T CELL LEUKEMIA LYMPHOMA; TUMOR SUPPRESSOR GENE;

ACUTE DISEASE; ADULT; CHRONIC DISEASE; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; GENES, P53; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 39649115217     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.12.007     Document Type: Article

References (43)

1. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult Tcell leukemia: clinical and hematological features of 16 cases. Blood 1977;50:481-92.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type-C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneous T-cell lymphoma. PNAS 1980;77:7415-9.
3. Yamada Y, Tomonaga M. The current status of therapy for adult T-cell leukaemia-lymphoma in Japan. Leuk Lymphoma 2003;44:611-8.
4. Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene 2005;24: 6047-57.
5. Kondo T, Kono H, Nonaka H, Miyamoto N, Yoshida R, Bando F, et al. Risk of adult T-cell leukemia/lymphoma in HTLV-I carriers. Lancet 1987;2:159.
6. Franchini G, Fukumoto R, Fullen JR. T-cell control by human T-cell leukemia/lymphoma virus type 1. Int J Hematol 2003;78:280-96.
7. Koiwa T, Hamano-Usami A, Ishida T, Okayama A, Yamagichi K, Kamihira S, et al. 5'-Long terminal repeat-selectiveCpGmethylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J Virol 2003;76:9389-97.
8. Hatta Y, Koeffler HP. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL). Leukemia 2002;16:1069-85.
9. Matsuoka M. Somatic alterations in adultT-cell leukemia cells [review]. Gann Monogr Cancer Res 2003;50:115-25.
10. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-7.
11. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30.
12. Serrano M, Hannon GY, Beach D. A new regulatory motif in cellcycle control cousin specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7.
13. Bartek J, Lukas J. Pathways governing G1/S transition and their response to DNA damage. FEBS Lett 2001;490:117-22.
14. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001;20:1803-15.
15. ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998;92:713-23.
16. ARF, participates in a regulatory feedback loop with p53 and MDM2.EMBO J 1998;17:5001-14.
17. Quelle DE, Zindy F, Ashmun RA, Sherr CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 1995;83:993-1000.
18. INK4A transcript. Cancer Res 1995;55:2995-7.
19. Hatta Y, Hirama T, Miller CW, Yamada Y, Tomonaga M, Koeffler HP. Homozygous deletion of the p15(MTS2) and p16(CDKN2/MTS1) genes in adult T-cell leukemia. Blood 1995;85:2699-704.
20. Yamada Y, Hatta Y, Murata K, Sugawara K, Ikeda S, Mine M, et al. Deletions of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. J Clin Oncol 1995;15:1778-85.
21. Takasaki Y, Yamada Y, Sugahara K, Hayashi T, Dateki N, Harasawa H, et al. Interruption of p16 gene expression in adult T-cell leukemia/lymphoma: clinical correlation. Br J Haematol 2003;122:253-9.
22. Davies JM, Hawe N, Kabarowski J, Huang Q-H, Zhu J, Brand NJ, et al. Novel BTB/POZ domain zinc finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 1999;18:365-75.
23. Kukita A, Kukita T, Ouchida M, Maeda H, Yatsuki H, Kohashi O. Osteoclast-derived zinc finger (OCZF) protein withPOZdomain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 1999;94:1987-97.
24. Pessler F, Pendergrast PS, Hernandez N. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol 1997;17:3786-98.
25. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, et al. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 2005;433:278-85.
26. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma. A report from the lymphoma study group (1984-1987). Br J Haematol 1991;79:428-37.
27. Yoshie O, Fujisawa R, NakayamaT, Harasawa H,Tago H, Izawa D, et al. Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells. Blood 2002;99:1505-11.
28. ARF tumor suppressor in acute myeloid leukemia. Nat Med 2002;8:743-50.
29. INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 1999;5:2704-13.
30. ARF tumor suppressor pathway in low grade diffuse astrocytomas and its influence on clinical course. Clin Cancer Res 2003;9:4884-90.
31. Tawara M, Hogerzeil SJ, Yamada Y, Takasaki Y, Soda H, Hasegawa H, et al. Impact of p53 aberration on the progression of Adult T-cell Leukemia/Lymphoma. Cancer Lett 2005;xx:1-7.
32. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996;85:27-37.
33. ARF links the tumor suppressor p53 to Ras. Nature 1998;395:125-6.
34. ARF. Cell 1997;91:649-59.
35. ARF tumor suppressor. Genes Dev 2000;14:2358-65.
36. Chen D, Kon N, Li M, Zhang W, Qin J, Gu W. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 2005;121:1071-83.
37. Hofmann WK, Tsukasaki K, Takeuchi N, Takeuchi S, Koeffler HP. Methylation analysis of cell cycle control genes in adult T-cell leukemia/lymphoma. Leuk Lymphoma 2001;42:1107-9.
38. Maeda T, Hobbs RM, Pansolfi PP. The transcription factor Pokemon: a new key player in cancer pathogenesis. Cancer Res 2005;65:8575-8.
39. ARF-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells. Blood 2000;95:3939-44.
40. Yin D, Xie D, Hofmann W, Miller CW, Black KL, Koeffler HP, et al. expression, and mutation analysis of the cell cycle control genes in human brain tumors. Oncogene 2002;21:8372-8.
41. Viswanathan M, Tsuchida N, Shanmugam G. Selective deletion of p14(ARF) exon 1β of the INK4a locus in oral squamous cell carcinomas of Indians. Oral Oncol 2001;37:341-4.
42. ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer. Clin Cancer Res 2004;10:4734-41.
43. Robertson KD, Jones PA. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by the wild-type p53. Mol Cell Biol 1998;18:6457-73.